TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›LMRI
LMRI logo

LMRI

Lumexa Imaging Holdings, Inc.

Next earnings ≈ Aug 11, 2026 · est. from filing cadence

Last earnings +3.3% on 2026-05-12

Sell
$12.43
▲ +7.25%
$12.43▼ -32.81%
over 1Y
L $6.77H $18.53
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+7.2%
1W+17.5%
1M+65.5%
3M+32.9%
YTD-29.2%
1Y-32.8%
OverviewValuationQualityTimelineFilings
Rating
Sell
Quality
—
Valuation
Fair value
Filings
Clean
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 14 analysts
Strong Buy

Mixed signals in the latest filings.

Lumexa Imaging Holdings, Inc. shows limited reported revenue.

On these fundamentals, the SEC-figure screen rates LMRI a SELL.

Is LMRI a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bear put spread~60d expiry
  • Long put 12.5 @ ~1.52 est
  • Short put 11 @ ~0.81 est
debit $71max +$79max −$71BE 11.79

SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Key statistics

Valuation

Enterprise value$1.19B
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash—

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 8-K Material agreement2026-06-30
  2. 8-K Shareholder vote2026-06-12
  3. 8-K Earnings results2026-05-12
  4. 10-Q Quarterly report2026-05-12
  5. DEF 14A Proxy statement2026-04-28
  6. 8-K Reg FD disclosure2026-04-09
  7. 10-K Annual report2026-03-30
  8. 8-K Earnings results2026-03-26
  9. 8-K Earnings results2026-03-02

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-302026-06-30open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗8-KPeriod ending 2026-06-102026-06-12open ↗4Period ending 2026-05-192026-05-21open ↗4Period ending 2026-05-142026-05-18open ↗10-QPeriod ending 2026-03-312026-05-12open ↗

Quality score

—
ValueGrowthProfitHealthMom.
Value—
Growth—
Profitability—
Financial health—
Momentum—
0.0052-week0.00
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals

Frequently asked

Is Lumexa Imaging Holdings, Inc. (LMRI) a buy?
LMRI currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.

Sources: SEC EDGAR (CIK 0002071288, latest 10-Q filed 2026-05-12) · EODHD · as of 6/18/2026, 1:03:41 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 18, 2026, 9:03 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 1 open-market buy · 0 sales

2026-06-10
Mittl Robert Louis Jr.
Director
Award19.4K
2026-06-10
Lungren Matthew
Director
Award19.4K
2026-06-10
Karlin Bridget E
Director
Award19.4K
2026-06-10
Joseph Molly
Director
Award19.4K
2026-06-10
EISENBERG GLENN A
Director
Award19.4K
2026-06-10
Cooper Henry Lee
Director
Award19.4K
2026-06-10
BRODNAX BRETT
Director
Award19.4K
2026-05-19
BRODNAX BRETT
Director
Buy35.0K @ $7.25$254K

Earnings history

beat/miss · move
2026-05-12Beat +45.3% est▲ +3.35%8-K ↗
2026-03-26Miss -374.3% est▼ -29.84%8-K ↗
2026-03-02Miss -374.3% est▲ +12.23%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Lumexa Imaging (LMRI) Q4 2025 Earnings TranscriptBullish
finance.yahoo.com· 2026-06-01
12 Health Care Stocks Moving In Wednesday's Intraday SessionBullish
finance.yahoo.com· 2026-05-13
Lumexa outlines 2026 revenue of $1.045B-$1.097B while targeting 8-10 de novo openingsBullish
seekingalpha.com· 2026-05-13
Lumexa Imaging Announces First Quarter 2026 ResultsBullish
globenewswire.com· 2026-05-12
Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call DateBullish
globenewswire.com· 2026-04-28
S&P Futures Slip on Middle East Conflict Uncertainty and China Trade ProbesBullish
finance.yahoo.com· 2026-03-27

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score— vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.2

News sentiment

EODHD · 3d
Bullish
+0.18
vs typical · 4 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.